{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:49:05Z","timestamp":1790567345301,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ophtha.2025.05.026","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T11:09:41Z","timestamp":1749208181000},"page":"1125-1133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Corticosteroids with or without Conventional Disease-Modifying Antirheumatic Drug as First-Line Therapy in Nonanterior Sarcoidosis Uveitis"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6084-995X","authenticated-orcid":false,"given":"Robin","family":"Jacquot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"S\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4036-7723","authenticated-orcid":false,"given":"Guillaume","family":"Mulier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Hankard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Maalouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3908-6716","authenticated-orcid":false,"given":"Laurent","family":"Kodjikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"El-Jammal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan","family":"Jamilloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e9laide","family":"Tout\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sales de Gauzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Domont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico","family":"Maestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine","family":"Ghembaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Touhami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Biard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Bodaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3628-9996","authenticated-orcid":false,"given":"David","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Claire","family":"Desbois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ophtha.2025.05.026_bib1","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","article-title":"Sarcoidosis","volume":"336","author":"Newman","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ophtha.2025.05.026_bib2","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"9","key":"10.1016\/j.ophtha.2025.05.026_bib3","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.3390\/jcm12093194","article-title":"Sarcoidosis-related uveitis: a review","volume":"12","author":"Giorgiutti","year":"2023","journal-title":"J Clin Med"},{"issue":"6 Pt 2","key":"10.1016\/j.ophtha.2025.05.026_bib4","first-page":"e349","article-title":"Ocular sarcoidosis","volume":"41","author":"Bodaghi","year":"2012","journal-title":"Presse Medicale Paris Fr 1983"},{"key":"10.1016\/j.ophtha.2025.05.026_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ajo.2018.12.016","article-title":"Serum angiotensin-converting enzyme has a high negative predictive value in the investigation for systemic sarcoidosis","volume":"201","author":"Niederer","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2025.05.026_bib6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10384-022-00927-y","article-title":"Clinical features of ocular sarcoidosis: severe, refractory, and prolonged inflammation","volume":"66","author":"Suzuki","year":"2022","journal-title":"Jpn J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2025.05.026_bib7","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1007\/s00417-022-05701-x","article-title":"Clinical features and visual outcomes of ocular sarcoidosis at a tertiary referral center in Tokyo","volume":"260","author":"Nagahori","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.ophtha.2025.05.026_bib8","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1136\/bjophthalmol-2020-317354","article-title":"Recommendations for the management of ocular sarcoidosis from the International Workshop on Ocular Sarcoidosis","volume":"105","author":"Takase","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2025.05.026_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1055\/s-0040-1710536","article-title":"Ocular sarcoidosis","volume":"41","author":"S\u00e8ve","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.ophtha.2025.05.026_bib10","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/bjophthalmol-2016-309767","article-title":"Long-term visual and systemic prognoses of 83 cases of biopsy-proven sarcoid uveitis","volume":"101","author":"Rochepeau","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.05.026_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ajo.2018.09.013","article-title":"Sarcoidosis-related uveitis: clinical presentation, disease course, and rates of systemic disease progression after uveitis diagnosis","volume":"198","author":"Ma","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2025.05.026_bib12","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ophtha.2025.05.026_bib13","first-page":"26","article-title":"Management of ocular sarcoidosis","volume":"29","author":"Baughman","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.ophtha.2025.05.026_bib14","doi-asserted-by":"crossref","first-page":"A97","DOI":"10.1016\/j.revmed.2022.03.285","article-title":"Effet b\u00e9n\u00e9fique du traitement immunosuppresseur dans les uv\u00e9ites non-ant\u00e9rieures de la sarco\u00efdose","volume":"43","author":"Leclercq","year":"2022","journal-title":"Rev M\u00e9decine Interne"},{"key":"10.1016\/j.ophtha.2025.05.026_bib15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ajo.2021.03.047","article-title":"Classification criteria for sarcoidosis-associated uveitis","volume":"228","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2025.05.026_bib16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.revmed.2008.08.011","article-title":"[Guidelines for the management of uveitis in internal medicine]","volume":"30","author":"Abad","year":"2009","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.ophtha.2025.05.026_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ajo.2022.04.007","article-title":"Evaluation of the SUN classification criteria for uveitides in an academic uveitis practice","volume":"241","author":"Mudie","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2025.05.026_bib18","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1136\/bjophthalmol-2018-313356","article-title":"Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis","volume":"103","author":"Mochizuki","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ophtha.2025.05.026_bib19","first-page":"913","article-title":"[Development of classification criteria for uveitis by the standardization of uveitis nomenclature (SUN) working group]","volume":"118","author":"Heiligenhaus","year":"2021","journal-title":"Ophthalmol Z Dtsch Ophthalmol Ges"},{"issue":"12","key":"10.1016\/j.ophtha.2025.05.026_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9123894","article-title":"Factors associated with ocular and extraocular recovery in 143 patients with sarcoid uveitis","volume":"9","author":"Bienvenu","year":"2020","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.ophtha.2025.05.026_bib21","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s00417-019-04415-x","article-title":"Ethnicity and association with ocular, systemic manifestations and prognosis in 194 patients with sarcoid uveitis","volume":"257","author":"Coulon","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"Pt 6","key":"10.1016\/j.ophtha.2025.05.026_bib22","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/eye.1999.221","article-title":"The ocular and systemic prognosis of patients presenting with sarcoid uveitis","volume":"13","author":"Edelsten","year":"1999","journal-title":"Eye (Lond)"},{"issue":"12","key":"10.1016\/j.ophtha.2025.05.026_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003432","article-title":"Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study","volume":"17","author":"Pujades-Rodriguez","year":"2020","journal-title":"PLoS Med"},{"issue":"11","key":"10.1016\/j.ophtha.2025.05.026_bib24","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/M20-1594","article-title":"Risk for serious infection with low-dose glucocorticoids in patients with rheumatoid arthritis : a cohort study","volume":"173","author":"George","year":"2020","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.ophtha.2025.05.026_bib25","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/art.42529","article-title":"Bone loss in inflammatory rheumatic musculoskeletal disease patients treated with low-dose glucocorticoids and prevention by anti-osteoporosis medications","volume":"75","author":"Adami","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.ophtha.2025.05.026_bib26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","article-title":"Long-term side effects of glucocorticoids","volume":"15","author":"Oray","year":"2016","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"10.1016\/j.ophtha.2025.05.026_bib27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ophtha.2022.02.002","article-title":"Outcomes of uveitic macular edema in the first-line antimetabolites as steroid-sparing treatment uveitis trial","volume":"129","author":"Tsui","year":"2022","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2025.05.026_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"5 Suppl 61","key":"10.1016\/j.ophtha.2025.05.026_bib29","first-page":"S145","article-title":"Use of methotrexate in patients with uveitis","volume":"28","author":"Ali","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ophtha.2025.05.026_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2017.09.003","article-title":"Toxicity risk from glucocorticoids in sarcoidosis patients","volume":"132","author":"Khan","year":"2017","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.ophtha.2025.05.026_bib31","first-page":"60","article-title":"Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial","volume":"17","author":"Baughman","year":"2000","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"5","key":"10.1016\/j.ophtha.2025.05.026_bib32","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MCP.0b013e3283642a7a","article-title":"Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide","volume":"19","author":"Cremers","year":"2013","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"10.1016\/j.ophtha.2025.05.026_bib33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12890-020-01290-9","article-title":"Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study","volume":"20","author":"Kahlmann","year":"2020","journal-title":"BMC Pulm Med"},{"issue":"10","key":"10.1016\/j.ophtha.2025.05.026_bib34","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jama.2019.12618","article-title":"Effect of corticosteroid-sparing treatment with mycophenolate mofetil vs methotrexate on inflammation in patients with uveitis: a randomized clinical trial","volume":"322","author":"Rathinam","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2025.05.026_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102481","article-title":"Comparison of conventional immunosuppressive drugs versus anti-TNF-\u03b1 agents in non-infectious non-anterior uveitis","volume":"113","author":"Leclercq","year":"2020","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.ophtha.2025.05.026_bib36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/bjo-2024-325163","article-title":"Methotrexate versus conventional disease-modifying antirheumatic drugs in the treatment of non-anterior sarcoidosis-associated uveitis","volume":"109","author":"Leclercq","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.05.026_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000336192","article-title":"Mycophenolate mofetil use in the treatment of noninfectious uveitis","volume":"51","author":"Klisovic","year":"2012","journal-title":"Dev Ophthalmol"},{"issue":"12","key":"10.1016\/j.ophtha.2025.05.026_bib38","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/jamaophthalmol.2019.3964","article-title":"Antimetabolite therapy for uveitis: methotrexate or mycophenolate?","volume":"137","author":"Jabs","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"Pt 3","key":"10.1016\/j.ophtha.2025.05.026_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/eye.1997.77","article-title":"Clinical diagnosis of ocular sarcoidosis","volume":"11","author":"Stavrou","year":"1997","journal-title":"Eye (Lond)"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642025003422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642025003422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:10:44Z","timestamp":1778944244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642025003422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0161642025003422"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2025.05.026","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corticosteroids with or without Conventional Disease-Modifying Antirheumatic Drug as First-Line Therapy in Nonanterior Sarcoidosis Uveitis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2025.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}]}}